Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
The effect of graded, physiologic hyperinsulinemia (+5, +15, +30, +70, +200 microU/ml) on oxidative and nonoxidative pathways of glucose and FFA metabolism was examined in nine lean non-insulin dependent diabetic patients (NIDDM) and in eight age- and weight-matched control subjects. Glucose and FFA metabolism were assessed using stepwise insulin clamp in combination with indirect calorimetry and infusion of [3H]3-glucose/[14C]palmitate. The basal rate of hepatic glucose production (HGP) was higher in NIDDM than in control subjects, and suppression of HGP by insulin was impaired at all but the highest insulin concentration. Glucose disposal was reduced in the NIDD patients at the three highest plasma insulin concentrations, and this was accounted for by defects in both glucose oxidation and nonoxidative glucose metabolism. In NIDDs, suppression of plasma FFA by insulin was impaired at all five insulin steps. This was associated with impaired suppression by insulin of plasma FFA turnover, FFA oxidation (measured by [14C]palmitate) and nonoxidative FFA disposal (an estimate of reesterification of FFA). FFA oxidation and net lipid oxidation (measured by indirect calorimetry) correlated positively with the rate of HGP in the basal state and during the insulin clamp. In conclusion, our findings demonstrate that insulin resistance is a general characteristic of glucose and FFA metabolism in NIDDM, and involves both oxidative and nonoxidative pathways. The data also demonstrate that FFA/lipid and glucose metabolism are interrelated in NIDDM, and suggest that an increased rate of FFA/lipid oxidation may contribute to the impaired suppression of HGP and diminished stimulation of glucose oxidation by insulin in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Plasma insulin concentrations such as those observed during the present insulin/glucose or glucose infusion studies, are known to completely suppress hepatic glucose production (27); thus, under these conditions, total glucose uptake is equal to exogenous glucose infusion.”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [27]
In the citing paper
“Notably, insulin resistance is also associated with a decreased ability to suppress lipolysis in adipose tissue and altered fatty acid oxidation.50,51”
From The effects of sleep disruption on metabolism, hunger, and satiety, and the influence of psychosocial stress and exercise: A narrative review (2024) · cites this paper as [51]
In the citing paper
“In lean healthy individuals insulin stimulates glucose uptake into skeletal muscle in a dose-dependent manner, with a half-maximal effect (EC50) at a plasma insulin concentration ~60 μU/mL [21].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“Using the gold standard euglycemic hyperinsulinemic clamp technique to quantify insulin-stimulated glucose uptake, they demonstrated that both lean and obese T2DM subjects have marked decrease (>50%) in whole body glucose disposal during the insulin clamp.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“During the postabsorptive state, the plasma insulin concentration is low. Since the plasma insulin concentration is the principal factor that restrains lipolysis in adipocytes [21] and stimulates glucose uptake in skeletal muscle [21], during the fasting state, muscle glucose uptake is low and the plasma FFA concentration is elevated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“More than 20 years ago Randle and co-workers introduced the concept of substrate competition, whereby enhanced availability and oxidation of FFA leads to an impairment in glucose oxidation (17).”
BackgroundImmunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
Self-citationRegulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 1×
“Since CPT I is inhibited by both insulin and malonyl-CoA, which is generated by condensation of acetyl-CoA (56), the insulin-mediated decline in FFA oxidation could have been due to a direct effect of the hormone on CPT I.”
BackgroundRelationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle
Neely, J. R., & Morgan, H. E. (1974) · Annual Review of Physiology · doi:10.1146/annurev.ph.36.030174.002213 · Cited by 1,261
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167 · cited 2×
“in insulin-mediated glucose metabolism affects both hepatic and peripheral tissues, primarily muscle (1-6).”
BackgroundSelf-citationEffect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Self-citationRadioimmunological determination of human C-peptide in serum
Heding, L. G. (1975) · Diabetologia · doi:10.1007/bf01222104 · Cited by 830
Kolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 629
DeFronzo, R. A., Simonson, D., & Ferrannini, E. (1982) · Diabetologia · doi:10.1007/bf00253736 · Cited by 541
Self-citationRegulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man
DeFronzo, R. A., Ferrannini, E., Hendler, R., Felig, P., & Wahren, J. (1983) · Diabetes · doi:10.2337/diab.32.1.35 · Cited by 509
Self-citationFactors Influencing the Rates of Long-Chain Fatty Acid Oxidation and Synthesis in Mammalian Systems
Fritz, I. B. (1961) · Physiological Reviews · doi:10.1152/physrev.1961.41.1.52 · Cited by 497
Thiebaud, D., Jacot, E., Defronzo, R. A., Maeder, E., Jequier, E., & Felber, J.-P. (1982) · Diabetes · doi:10.2337/diacare.31.11.957 · Cited by 489
Self-citationProinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.
Horwitz, D. L., Starr, J. I., Mako, M. E., Blackard, W. G., & Rubenstein, A. H. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108047 · Cited by 473 · cited 1×
“The portosystemic insulin concentration gradient was assumed to be 3 (44).”
BackgroundBogardus, C., Lillioja, S., Howard, B. V., Reaven, G., & Mott, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111533 · Cited by 397
Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver.
Williamson, J. R., Kreisberg, R. A., & Felts, P. W. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.56.1.247 · Cited by 386
A microfluorometric method for the determination of free fatty acids in plasma
Miles, J., Glasscock, R., Aikens, J., Gerich, J., & Haymond, M. (1983) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38029-9 · Cited by 329
An Abnormality of Nonesterified Fatty Acid Metabolism in Diabetes Mellitus
Bierman, E. L., Dole, V. P., & Roberts, T. N. (1957) · Diabetes · doi:10.2337/diab.6.6.475 · Cited by 326
Role of Lipid Oxidation in Pathogenesis of Insulin Resistance of Obesity and Type II Diabetes
Felber, J.-P., Ferrannini, E., Golay, A., Meyer, H. U., Theibaud, D., Curchod, B., Maeder, E., Jequier, E., & DeFronzo, R. A. (1987) · Diabetes · doi:10.2337/diab.36.11.1341 · Cited by 277
Self-citationAn Abnormality of Nonesterified Fatty Acid Metabolism in Diabetes Mellitus
Bierman, E. L., Dole, V. P., & Roberts, T. N. (1958) · Diabetes · doi:10.2337/diab.7.3.189 · Cited by 277
New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus
Defronzo, R. A., Ferrannini, E., & Koivisto, V. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90654-x · Cited by 262
Self-citationDagenais, G. R., Tancredi, R. G., & Zierler, K. L. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108486 · Cited by 238
FRAZE, E., DONNER, C. C., SWISLOCKI, A. L. M., CHIOU, Y. A. M., CHEN, Y. D. I., & REAVEN, G. M. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-5-807 · Cited by 215
CHEN, Y.-D. I., GOLAY, A., SWISLOCKI, A. L. M., & REAVEN, G. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-17 · Cited by 177
Uptake of individual free fatty acids by skeletal muscle and liver in man
Hagenfeldt, L., Wahren, J., Pernow, B., & Räf, L. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107043 · Cited by 170
Regulation of hepatic glucose metabolism in humans
DeFronzo, R. A., & Ferrannini, E. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030204 · Cited by 167
Self-citationValidation of a new method for determination of free fatty acid turnover
Miles, J. M., Ellman, M. G., McClean, K. L., & Jensen, M. D. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.3.e431 · Cited by 161
Golay, A., Swislocki, A., Chen, Y. I., & Reaven, G. M. (1987) · Metabolism · doi:10.1016/0026-0495(87)90156-9 · Cited by 155
Relationship between insulin-mediated glucose disposal and lipid metabolism in man.
Lillioja, S., Bogardus, C., Mott, D. M., Kennedy, A. L., Knowler, W. C., & Howard, B. V. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111804 · Cited by 150 · cited 2×
“Thereafter, a number of studies have confirmed that elevated rates of lipid oxidation are associated with impaired oxidative glucose disposal in nondiabetic and NIDD subjects (18-24).”
BackgroundNon-steady state: error analysis of Steele's model and developments for glucose kinetics
Cobelli, C., Mari, A., & Ferrannini, E. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.5.e679 · Cited by 148
Self-citationRole of Free Fatty Acids in Glucose Homeostasis
Ruderman, N. B. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.123.3.299 · Cited by 147
Oxidation of plasma FFA in lean and obese humans
Issekutz, B., Jr., Paul, P., Miller, H. I., & Bortz, W. M. (1968) · Metabolism · doi:10.1016/s0026-0495(68)80008-3 · Cited by 136
Glucose turnover values in the dog obtained with various species of labeled glucose
Altszuler, N., Barkai, A., Bjerknes, C., Gottlieb, B., & Steele, R. (1975) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1975.229.6.1662 · Cited by 131
Carnitine Biosynthesis, Metabolism, and Functions
(1980) · Elsevier eBooks · doi:10.1016/b978-0-122-67060-2.x5001-9 · Cited by 121
Carnitine biosynthesis, metabolism, and functions
Frenkel, R., & McGarry, J. (1980) · Medical Entomology and Zoology · Cited by 117
Arner, P., Bolinder, J., Engfeldt, P., & Östman, J. (1981) · Metabolism · doi:10.1016/0026-0495(81)90020-2 · Cited by 114
LILLIOJA, S., MOTT, D. M., ZAWADZKI, J. K., YOUNG, A. A., ABBOTT, W. G., & BOGARDUS, C. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-922 · Cited by 111 · cited 1×
“However, it remains unproven whether enhanced lipid oxidation also inhibits the nonoxidative pathways of glucose metabolism (21-26).”
BackgroundTurnover rate of plasma FFA in humans and in dogs
Issekutz, B., Jr., Bortz, W. M., Miller, H. I., & Paul, P. (1967) · Metabolism · doi:10.1016/0026-0495(67)90093-5 · Cited by 107
Felber, J. P., Meyer, H. U., Curchod, B., Iselin, H. U., Rousselle, J., Maeder, E., Pahud, P., & Jéquier, E. (1981) · Diabetologia · doi:10.1007/bf00253814 · Cited by 98
Source of fat oxidation in exercising dogs
Issekutz, B., Miller, H. I., Paul, P., & Rodahl, K. (1964) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1964.207.3.583 · Cited by 98
Pb, G., & Pj, R. (1964) · PubMed · Cited by 97
Taskinen, M. R., Bogardus, C., Kennedy, A., & Howard, B. V. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112016 · Cited by 85
Turnover of individual free fatty acids in man.
Hagenfeldt, L. (1975) · PubMed · Cited by 84
Balasse, E. O., & Neef, M. A. (1974) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1974.tb00400.x · Cited by 82
Lönnroth, P., Digirolamo, M., Krotkiewski, M., & Smith, U. (1983) · Diabetes · doi:10.2337/diab.32.8.748 · Cited by 74
Radziuk, J., Norwich, K. H., & Vranić, M. (1974) · PubMed · Cited by 73
Bolinder, J., Östman, J., & Arner, P. (1982) · Diabetes · doi:10.2337/diab.31.10.911 · Cited by 69
Howard, B. V., Savage, P. J., NAGULESPARAN, M., Bennion, L. J., Unger, R. H., & Bennett, P. H. (1979) · Metabolism · doi:10.1016/0026-0495(79)90180-x · Cited by 64
Blumenthal, S. A. (1983) · Metabolism · doi:10.1016/0026-0495(83)90137-3 · Cited by 64
Nankervis, A. J., Proietto, J., Aitken, P. M., Harewood, M. S., & ALFORD, F. P. (1982) · Diabetologia · doi:10.1007/bf00253737 · Cited by 59
Boden, G., Ray, T. K., Smith, R. H., & Owen, O. E. (1983) · Diabetes · doi:10.2337/diab.32.11.982 · Cited by 53
Radioimmunological Determination of Human C-Peptide in Serum
Hedïng, L. G. (1988) · Springer eBooks · doi:10.1007/978-94-011-7094-9_10 · Cited by 48
Shulman, G. I., Williams, P. E., LILJENQUIST, J. E., LACY, W. W., Keller, U. B., & Cherrington, A. D. (1980) · Metabolism · doi:10.1016/0026-0495(80)90004-9 · Cited by 46
Effect of glucose ingestion on the metabolism of free fatty acids in human subjects
Waterhouse, C., Baker, N., & Rostami, H. (1969) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43039-1 · Cited by 45
Metabolic factors in the insulin resistance in human obesity
Meylan, M., Henny, C., Temler, E., Jéquier, E., & Felber, J. P. (1987) · Metabolism · doi:10.1016/0026-0495(87)90185-5 · Cited by 38
Hagenfeldt, L., & Wahren, J. (1972) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517209080281 · Cited by 34
Influence of parenteral carbohydrate on fat oxidation in surgical patients.
Robin, A. P., Nordenström, J., ASKANAZI, J., Ya, C., Elwyn, D. H., & Jm, K. (1984) · PubMed · Cited by 34
Bolinder, J., Ostman, J., & Arner, P. (1982) · Diabetes · doi:10.2337/diabetes.31.10.911 · Cited by 32
The Relationship Between Serum Free Fatty Acids and Blood Sugar in Non‐obese and Obese Diabetics
Reitsma, W. D. (1967) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1967.tb11535.x · Cited by 27
Relation of fatty acid oxidation to gluconeogenesis: Effect of pentenoic acid
Ruderman, N. B., Shafrir, E., & BRESSLER, R. C. (1968) · Life Sciences · doi:10.1016/0024-3205(68)90145-8 · Cited by 27
Boden, G., Ray, T. K., Smith, R. H., et al. (1983) · Diabetes · doi:10.2337/diabetes.32.11.982 · Cited by 25
BALASSE, E. O., & Neef, M. A. (1974) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1974.tb02342.x · Cited by 15
Felber, J. P., Meyer, H. U., Curchod, B., Iselin, H. U., Rousselle, J., Maeder, E., Pahud, P., & Jéquier, E. (1981) · Diabetologia · doi:10.1007/bf01789111 · Cited by 11
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
“(26) demonstrated that the antilipolytic effect of insulin was markedly impaired in lean type 2 diabetic subjects, as well as in obese nondiabetic subjects (140).”
BackgroundMethodInfluentialSelf-citationDeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
Self-citationMuniyappa, R., Lee, S., Chen, H., & Quon, M. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2007 · Cited by 1,643
“Similarly, radiolabeled tracers of glycerol or amino acids may be used during the glucose clamp to assess insulin sensitivity with respect to lipolysis or protein metabolism (42, 44).”
MethodPathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342
“7) [1,2,12,114].”
InfluentialSelf-citation
Metadata
- Authors
- Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- University of Helsinki (FI)
- Venue
- Journal of Clinical Investigation
- Published
- 1989-07-01
- Volume
- 84
- Issue
- 1
- Pages
- 205-213
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC303971
- OpenAlex
- W1981456793
- Cited by
- 812
- References
- 61
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 28 · 2023: 15 · 2022: 27 · 2021: 30 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 32 · 2016: 26 · 2015: 22 · 2014: 22 · 2013: 26 · 2012: 26
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health (AM 24 092)
- Fogarty International Center (F05-TWO-3451)
- National Center for Research Resources (RR 125)
- Ministero dell'Istruzione e del Merito
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- type 2 diabetes, insulin resistance, glucose metabolism, free fatty acid metabolism, hepatic glucose production, glucose oxidation, nonoxidative glucose metabolism, fatty acid oxidation, fatty acid re-esterification, hyperinsulinemia, insulin clamp, lipid oxidation
- MeSH terms
- Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Oxidation-Reduction, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.